Abstract
Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein.
Tomohisa Sekimoto, Koichi Hamada, Yuichi Oike, Tomomi Matsuoka, Masanori Matsumoto, Etsuo Chosa, Toshio Suda, Naoya Tajima and Ken-Ichi Yamamura
The Journal of Rheumatology February 2002, 29 (2) 240-245;
Tomohisa Sekimoto
Koichi Hamada
Yuichi Oike
Tomomi Matsuoka
Masanori Matsumoto
Etsuo Chosa
Toshio Suda
Naoya Tajima
In this issue
Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein.
Tomohisa Sekimoto, Koichi Hamada, Yuichi Oike, Tomomi Matsuoka, Masanori Matsumoto, Etsuo Chosa, Toshio Suda, Naoya Tajima, Ken-Ichi Yamamura
The Journal of Rheumatology Feb 2002, 29 (2) 240-245;
Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein.
Tomohisa Sekimoto, Koichi Hamada, Yuichi Oike, Tomomi Matsuoka, Masanori Matsumoto, Etsuo Chosa, Toshio Suda, Naoya Tajima, Ken-Ichi Yamamura
The Journal of Rheumatology Feb 2002, 29 (2) 240-245;